发明名称 |
3-methyl-2- ( (2S) -2- (4- (3-methyl-L, 2, 4-oxadiazol-5-YL) phenyl) morpholino) -6- (pyrim-idin-4-yl) pyrimidin-4 (3H) -one as tau protein kinase inhibitor |
摘要 |
A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g. Alzheimer disease). |
申请公布号 |
US8288383(B2) |
申请公布日期 |
2012.10.16 |
申请号 |
US20080677161 |
申请日期 |
2008.09.12 |
申请人 |
SAKAI DAIKI;WATANABE KAZUTOSHI;SANOFI |
发明人 |
SAKAI DAIKI;WATANABE KAZUTOSHI |
分类号 |
A61K31/535;C07D413/14 |
主分类号 |
A61K31/535 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|